We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FIBI:TASEFirst International Bank of Israel Ltd Analysis

Data as of 2026-06-13 - not real-time

ILA 29,960.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

F.I.B.I. Holdings trades at 29,960 ILA, just above the identified support of 28,600 and slightly below its 20‑day (30,275) and 50‑day (30,756) moving averages, suggesting a short‑term price ceiling. The RSI sits at 47, indicating a neutral momentum stance, while the MACD line remains beneath its signal with a negative histogram, flagging bearish short‑term pressure. Despite this technical backdrop, the stock's valuation appears attractive: a trailing P/E of 10.28 is well under the industry average of 16.83, and the price‑to‑book ratio of 1.5 aligns with a modest discount to book value. The dividend yield of 7.91% coupled with a payout ratio of 45% underscores a generous and potentially sustainable income stream, reinforced by a massive cash pile of 76.9 B ILA against 18.4 B ILA of debt. Low beta (0.31) points to limited systematic risk, yet the 30‑day volatility of 32% signals notable price swings. The DCF‑derived fair value of roughly 180,891 ILA implies a deep undervaluation relative to the current market price, further bolstering the case for a value‑oriented entry point.
In sum, the combination of a solid balance sheet, strong dividend yield, and clear valuation headroom outweighs the near‑term bearish technical signals, positioning FIBI as a compelling candidate for investors seeking stable income and upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the 28,600 support level
  • Bearish MACD histogram indicating downward pressure
  • High dividend yield of 7.91% providing income cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (P/E 10.28 vs industry 16.83)
  • Robust cash position and low leverage
  • Market sentiment reflected by extreme greed index

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend supported by a 45% payout ratio
  • Low systematic risk (beta 0.31) and stable banking fundamentals
  • Deep undervaluation indicated by DCF fair value far above price

Key Metrics & Analysis

Financial Health

Revenue Growth-1.80%
Profit Margin15.50%
P/E Ratio10.3
ROE15.49%
ROA0.88%
P/B Ratio1.5
Op. Cash FlowILA604.0M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI47.2
SupportILA 28,600.00
ResistanceILA 31,800.00
MA 20ILA 30,275.00
MA 50ILA 30,756.20
MA 200ILA 28,628.35
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueILA 180,890.80
GradeUndervalued
TypeValue
Dividend Yield7.91%

Risk Assessment

Beta0.00
Volatility32.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.